¸¸¼ºÄáÆϺ´ ¹Ì³×¶ö-»ÀÁúȯ ¿¬±¸È¸ New paradiagm of CKD MBD management : 2019-09-29 |
|
¸¸¼ºÄáÆϺ´ ¹Ì³×¶ö-»ÀÁúȯ ¿¬±¸È¸ New paradiagm of CKD MBD management : 2019-09-29 ±³À°ÀÏÀÚ : 2019-09-29 ±³À°Àå¼Ò : ¼¿ï/ °í´ë±¸·Îº´¿ø »õ·Ò ±³À°°ü 1Ãþ ´ë°´ç ±³À°ÁÖÁ¦ : New paradiagm of CKD MBD management ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ ½ÃÇà±â°ü(ÁöºÎ/°ú) : ¸¸¼ºÄáÆϺ´ ¹Ì³×¶ö-»ÀÁúȯ ¿¬±¸È¸ ´ã´çÀÚ : ¾È½Å¿µ ¿¬¶ôó : 02-000-0000 À̸ÞÀÏ : ahnshinyoung712@gmail.com ±³À°Á¾·ù : ³»°ú Âü¼®¿¹»óÀοø : 200¸í Èñ¸ÁÆòÁ¡ : 5Á¡ Áö¿ª : ¼¿ïƯº°½Ã ±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ ¼¼ºÎ¼ö°·á : 40,000¿ø ºñ°í »çÀüµî·Ï: Àü¹®ÀÇ 3¸¸¿ø/ ÀüÀÓÀÇ, Àü°øÀÇ ¹× °£È£»ç 2¸¸¿øÇöÀåµî·Ï: Àü¹®ÀÇ 4¸¸¿ø/ ÀüÀÓÀÇ, Àü°øÀÇ ¹× °£È£»ç 3¸¸¿ø ±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ ±³À°½Ã°£ 09-29 ´ë°´ç 08:30~08:55 Favor Polymers including sevelamer È«À¯¾Æ(Ä«Å縯ÀÇ´ë ½ÅÀå³»°ú) ±³À°½Ã°£ 09-29 ´ë°´ç 08:55~09:20 Favor Metals including lanthanum, calcium, & magnesium ÀÌÁöÀº(¿ø±¤´ëÀÇ´ë ½ÅÀå³»°ú) ±³À°½Ã°£ 09-29 ´ë°´ç 09:20~09:45 Favor rookies in Korea: Iron ÀÌ¿µ±â(ÇѸ²´ëÀÇ´ë ½ÅÀå³»°ú) ±³À°½Ã°£ 09-29 ´ë°´ç 09:45~10:10 Favor VDRA ±è⼺(Àü³²´ëÀÇ´ë ½ÅÀå³»°ú) ±³À°½Ã°£ 09-29 ´ë°´ç 10:10~10:35 Favor cinacalcet ÃÖ¹ü¼ø(Ä«Å縯ÀÇ´ë ½ÅÀå³»°ú) ±³À°½Ã°£ 09-29 ´ë°´ç 10:35~11:00 Favor parathyroidectomy °í°Áö(°í·Á´ëÀÇ´ë ½ÅÀå³»°ú) ±³À°½Ã°£ 09-29 ´ë°´ç 11:00~11:40 Management of Secondary hyperparathyroidism in Japan including new calcimimetics (evocalcet and etelcalcetide) Masafumi Fukagawa(Tokai University) ±³À°½Ã°£ 09-29 ´ë°´ç 12:00~12:25 Pathophysiology and Diagnosis of vascular calcification ¾È¿ø¼®(µ¿¾Æ´ëÀÇ´ë ½ÅÀå³»°ú) ±³À°½Ã°£ 09-29 ´ë°´ç 12:25~12:45 Treatment of vascular calcification ¿À±¹È¯(¼¿ï´ëÀÇ´ë ½ÅÀå³»°ú) ±³À°½Ã°£ 09-29 ´ë°´ç 12:45~13:05 Physical activity for prevention and amelioration of Osteoporosis °¼®(°í·Á´ëÀÇ´ë ÀçÈ°ÀÇÇаú) ±³À°½Ã°£ 09-29 ´ë°´ç 13:05~13:30 Osteoporosis management in CKD – Case Review ±Ç¿µÁÖ(°í·Á´ëÀÇ´ë ½ÅÀå³»°ú) ±³À°½Ã°£ 09-29 ´ë°´ç 13:30~13:50 FLS (Fracture Liaison Service) in CKD ÇÏ¿ëÂù(Áß¾Ó´ëÀÇ´ë Á¤Çü¿Ü°ú) |
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. |
|